Editor
Editing Team @ Stockchase at Stockchase Inc.
Member since: May '07 · 48 Opinions
Rating
Big Win
Win
Neutral
Loss
Big Loss
Stock Opinions by Editor
As mentioned in our May report to Stockchase subscribers, Moderna (with NIH) began Phase 1 testing for a vaccine back in March. If the drug pasts future tests, Moderna and Swiss drugmaker, Lonza, will produce the drug together. Monday’s news puts Moderna as the frontrunner in the vaccine race and lifted its stock 27% to 84% year-to-date.
PLUG is a risky investment. CNN Business thinks the following for the next 12 months: "The 8 analysts offering 12-month price forecasts for Plug Power Inc. have a median target of $4.00." Experts on Stockchase did not review this stock yet, you can find more information on Tradingview.
A cannabis company. It specializes in research & development related to cannabis. It's a very speculative stock. Experts on Stockchase haven't commented on this stock y et. You can get more informations and analysis on Tradingview.
